Literature DB >> 23443666

Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING).

Fernando Souza-Fonseca-Guimaraes1, Marianna Parlato, Rosane B de Oliveira, Douglas Golenbock, Katherine Fitzgerald, Irina N Shalova, Subhra K Biswas, Jean-Marc Cavaillon, Minou Adib-Conquy.   

Abstract

Natural killer (NK) cells are important for innate immunity in particular through the production of IFN-γ and GM-CSF. Both cytokines are important in restoration of immune function of tolerized leukocytes under inflammatory events. The expression of TLRs in NK cells has been widely studied by analyzing the mRNA of these receptors, rarely seeking their protein expression. We previously showed that murine spleen NK cells express TLR9 intracellularly and respond to CpG oligodeoxynucleotide (CpG-ODN) by producing IFN-γ and GM-CSF. However, to get such production the presence of accessory cytokines (such as IL-15 and IL-18) was required, whereas CpG-ODN or accessory cytokines alone did not induce IFN-γ or GM-CSF. We show here that TLR9 overlaps with the Golgi apparatus in NK cells. Furthermore, CpG-ODN stimulation in the presence of accessory cytokines induces the phosphorylation of c-Jun, STAT3, and IκBα. IFN-γ and GM-CSF production requires NF-κB and STAT3 activation as well as Erk-dependent mechanisms for IFN-γ and p38 signaling for GM-CSF. Using knock-out-mice, we show that UNC93b1 and IL-12 (produced by NK cells themselves) are also necessary for IFN-γ and GM-CSF production. IFN-γ production was found to be MyD88- and TLR9-dependent, whereas GM-CSF was TLR9-independent but dependent on STING (stimulator of interferon genes), a cytosolic adaptor recently described for DNA sensing. Our study thereby allows us to gain insight into the mechanisms of synergy between accessory cytokines and CpG-ODN in NK cells. It also identifies a new and alternative signaling pathway for CpG-ODN in murine NK cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23443666      PMCID: PMC3624451          DOI: 10.1074/jbc.M112.435602

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation.

Authors:  Hélène Beuneu; Jacques Deguine; Isabelle Bouvier; James P Di Santo; Matthew L Albert; Philippe Bousso
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

2.  IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.

Authors:  Meghan J Chenoweth; M Firoz Mian; Nicole G Barra; Tommy Alain; Nahum Sonenberg; Jonathan Bramson; Brian D Lichty; Carl D Richards; Averil Ma; Ali A Ashkar
Journal:  J Immunol       Date:  2012-03-23       Impact factor: 5.422

Review 3.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

4.  Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cells.

Authors:  Naoko Kanda; Masahiro Kamata; Yayoi Tada; Takeko Ishikawa; Shinichi Sato; Shinichi Watanabe
Journal:  J Leukoc Biol       Date:  2011-03-02       Impact factor: 4.962

5.  Streptococcus pneumoniae stimulates a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs.

Authors:  Uwe Koppe; Katrin Högner; Jan-Moritz Doehn; Holger C Müller; Martin Witzenrath; Birgitt Gutbier; Stefan Bauer; Thomas Pribyl; Sven Hammerschmidt; Jürgen Lohmeyer; Norbert Suttorp; Susanne Herold; Bastian Opitz
Journal:  J Immunol       Date:  2011-12-12       Impact factor: 5.422

Review 6.  Compartment-specific control of signaling from a DNA-sensing immune receptor.

Authors:  Alex Engel; Gregory M Barton
Journal:  Sci Signal       Date:  2010-11-30       Impact factor: 8.192

7.  CpG and non-CpG oligodeoxynucleotides directly costimulate mouse and human CD4+ T cells through a TLR9- and MyD88-independent mechanism.

Authors:  Angela Landrigan; Michael T Wong; Paul J Utz
Journal:  J Immunol       Date:  2011-08-15       Impact factor: 5.422

8.  IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells.

Authors:  Jeanette E Boudreau; Kyle B Stephenson; Fuan Wang; Ali A Ashkar; Karen L Mossman; Laurel L Lenz; Kenneth L Rosenthal; Jonathan L Bramson; Brian D Lichty; Yonghong Wan
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

9.  NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis.

Authors:  Fernando Souza-Fonseca-Guimaraes; Marianna Parlato; Catherine Fitting; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  J Immunol       Date:  2012-05-07       Impact factor: 5.422

10.  Role of the JNK/c-Jun/AP-1 signaling pathway in galectin-1-induced T-cell death.

Authors:  B Brandt; E F Abou-Eladab; M Tiedge; H Walzel
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

View more
  10 in total

1.  Different expressions of TLRs and related factors in peripheral blood of preterm infants.

Authors:  Jinping Zhang; Jianguo Zhou; Baogan Xu; Chao Chen; Wenjing Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity.

Authors:  Rana Falahat; Patricio Perez-Villarroel; Adam W Mailloux; Genyuan Zhu; Shari Pilon-Thomas; Glen N Barber; James J Mulé
Journal:  Cancer Immunol Res       Date:  2019-08-28       Impact factor: 11.151

3.  Transcriptional profile in afferent lymph cells following vaccination with liposomes incorporating CpG.

Authors:  Melanie R Neeland; Martin J Elhay; David R Powell; Fernando J Rossello; Els N T Meeusen; Michael J de Veer
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

Review 4.  NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Med Oncol       Date:  2022-06-18       Impact factor: 3.064

Review 5.  Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?

Authors:  Fernando Souza-Fonseca-Guimaraes; Jean-Marc Cavaillon; Minou Adib-Conquy
Journal:  Crit Care       Date:  2013-08-27       Impact factor: 9.097

6.  Targeting dendritic cells to accelerate T-cell activation overcomes a bottleneck in tuberculosis vaccine efficacy.

Authors:  Kristin L Griffiths; Mushtaq Ahmed; Shibali Das; Radha Gopal; William Horne; Terry D Connell; Kelly D Moynihan; Jay K Kolls; Darrell J Irvine; Maxim N Artyomov; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Nat Commun       Date:  2016-12-22       Impact factor: 14.919

Review 7.  STING Signaling and Sterile Inflammation.

Authors:  Isabelle Couillin; Nicolas Riteau
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

8.  Deregulated JAK3 mediates growth advantage and hemophagocytosis in extranodal nasal-type natural killer/T-cell lymphoma.

Authors:  Adrien Picod; Suella Martino; Pascale Cervera; Gregory Manuceau; Marc Arca; Monica Wittner; YanYan Zhang; He Liang; Florian Beghi; Eric Solary; Fawzia Louache; Paul Coppo
Journal:  Haematologica       Date:  2022-09-01       Impact factor: 11.047

Review 9.  "Natural Regulators": NK Cells as Modulators of T Cell Immunity.

Authors:  Iona S Schuster; Jerome D Coudert; Christopher E Andoniou; Mariapia A Degli-Esposti
Journal:  Front Immunol       Date:  2016-06-14       Impact factor: 7.561

Review 10.  Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases.

Authors:  Yuhao Jiao; Li Wu; Nicholas D Huntington; Xuan Zhang
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.